INTRA CELLULAR THERAPIES INC's ticker is and the CUSIP is 46116X901. A total of 4 filers reported holding INTRA CELLULAR THERAPIES INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $619,871 | -51.8% | 11,900 | -41.4% | 0.00% | -50.0% |
| Q2 2023 | $1,285,396 | -45.4% | 20,300 | -53.3% | 0.00% | -55.6% |
| Q1 2023 | $2,355,525 | +319.9% | 43,500 | +310.4% | 0.01% | +800.0% |
| Q4 2022 | $560,952 | -56.9% | 10,600 | -62.1% | 0.00% | -66.7% |
| Q3 2022 | $1,303,000 | -21.0% | 28,000 | -3.1% | 0.00% | 0.0% |
| Q2 2022 | $1,650,000 | -59.9% | 28,900 | -57.1% | 0.00% | -25.0% |
| Q1 2022 | $4,118,000 | -11.3% | 67,300 | -24.1% | 0.00% | 0.0% |
| Q4 2021 | $4,643,000 | +90.8% | 88,700 | +35.8% | 0.00% | +33.3% |
| Q3 2021 | $2,434,000 | +16.0% | 65,300 | +27.0% | 0.00% | 0.0% |
| Q2 2021 | $2,098,000 | +90.2% | 51,400 | +58.2% | 0.00% | +50.0% |
| Q1 2021 | $1,103,000 | -64.3% | 32,500 | -66.5% | 0.00% | -60.0% |
| Q4 2020 | $3,088,000 | -2.0% | 97,100 | -20.9% | 0.01% | -50.0% |
| Q3 2020 | $3,151,000 | -13.8% | 122,800 | -13.8% | 0.01% | -41.2% |
| Q2 2020 | $3,655,000 | +339.3% | 142,400 | +163.2% | 0.02% | +142.9% |
| Q1 2020 | $832,000 | -93.6% | 54,100 | -85.8% | 0.01% | -92.1% |
| Q4 2019 | $13,048,000 | +2819.0% | 380,300 | +536.0% | 0.09% | +2125.0% |
| Q3 2019 | $447,000 | -29.6% | 59,800 | +22.3% | 0.00% | -33.3% |
| Q2 2019 | $635,000 | -59.2% | 48,900 | -61.7% | 0.01% | -64.7% |
| Q1 2019 | $1,557,000 | -80.3% | 127,800 | -81.5% | 0.02% | -75.0% |
| Q4 2018 | $7,886,000 | +219.7% | 692,400 | +509.0% | 0.07% | +257.9% |
| Q3 2018 | $2,467,000 | +131.9% | 113,700 | +88.9% | 0.02% | +111.1% |
| Q2 2018 | $1,064,000 | -51.9% | 60,200 | -42.7% | 0.01% | -59.1% |
| Q1 2018 | $2,210,000 | +531.4% | 105,000 | +333.9% | 0.02% | +1000.0% |
| Q4 2017 | $350,000 | +39.4% | 24,200 | +52.2% | 0.00% | 0.0% |
| Q3 2017 | $251,000 | +234.7% | 15,900 | +165.0% | 0.00% | +100.0% |
| Q2 2017 | $75,000 | -51.3% | 6,000 | -36.8% | 0.00% | -50.0% |
| Q1 2017 | $154,000 | +161.0% | 9,500 | +143.6% | 0.00% | +100.0% |
| Q4 2016 | $59,000 | -94.6% | 3,900 | -94.6% | 0.00% | -91.7% |
| Q3 2016 | $1,097,000 | -55.6% | 72,000 | +13.2% | 0.01% | -58.6% |
| Q2 2016 | $2,469,000 | +140.6% | 63,600 | +72.4% | 0.03% | +107.1% |
| Q1 2016 | $1,026,000 | +132.7% | 36,900 | +350.0% | 0.01% | +180.0% |
| Q4 2015 | $441,000 | -78.2% | 8,200 | -83.8% | 0.01% | -82.1% |
| Q3 2015 | $2,026,000 | +33666.7% | 50,600 | +25200.0% | 0.03% | – |
| Q2 2015 | $6,000 | – | 200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 43,500 | $2,355,525 | 0.01% |
| JANE STREET GROUP, LLC | 180,500 | $9,774,075 | 0.00% |
| SIMPLEX TRADING, LLC | 57,000 | $3,086 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |